Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Wed, 29th Apr 2015 05:14

UK AGM, EGM Calendar
Wednesday, April 29
Segro
MTI Wireless Edge
Countrywide
British American Tobacco
Aggreko
Aviva
HellermannTyton
Kennedy Wilson Europe Real Estate
EMIS
Global Invacom Group
Nichols
Admiral
Aberdeen UK Tracker Trust 
Asian Total Return Investment Company 
Devro
Fidessa Group
Lancashire Holdings
Alliance Trust
Weir Group
Polar Capital Global Financials Trust 
EP Global Opportunities Trust
London Stock Exchange Group
Thursday, April 30
Berendsen
Alkane Energy
Colt Group
Ashtead Group
James Fisher & Sons
Synthomer
Ultra Electronics Holdings
Modern Water
Schroders
Tullow Oil
Anglo Pacific
STV Group
Witan Investment Trust
LSL Property
IndigoVision
ARM Holdings
GLI Finance
International Personal Finance
Moneysupermerket.com
RIT Capital Partners
Unilever
Everyman Media Group
Fyffes
BT
H&T Group
Friday, May 1
Aer Lingus
SVG Capital
Jardine Lloyd Thompson Group
Virgin Money
Fairpoint
Electric Word
Capital & Counties Properties
RPS Group
Smurfit Kappa
Silence Therapeutics
Monday, May 4
No Events Scheduled 
Tuesday, May 5
Catlin Group
Randgold Resources
Macfarlane Group
BG Group
Burford Capital
GVC Holdings
Henderson High Income
Spirent Communications
Stratex International
Sherborne Investors
 
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
8 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Jun 2021 08:51

Silence Therapeutics to present positive data from 'SLN124'

(Sharecast News) - Silence Therapeutics announced on Monday that it would present data showing the potential for 'SLN124' to address a range of hematological diseases by targeting the liver-expressed gene TMPRSS6.

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
25 May 2021 19:40

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

Read more
25 May 2021 12:35

Silence Therapeutics receives remaining $40m from AstraZeneca partnership

(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
19 May 2021 10:20

Silence Therapeutics reveals positive data from SLN124 study

(Sharecast News) - Silence Therapeutics announced positive topline data from the 'GEMINI' phase 1 study of its wholly-owned product candidate 'SLN124' in healthy volunteers on Wednesday.

Read more
29 Apr 2021 14:34

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Read more
29 Apr 2021 09:48

Silence Therapeutics doses first patient in 'GEMINI II' study

(Sharecast News) - Silence Therapeutics announced on Thursday that the first patient has been dosed in the 'GEMINI II' phase 1 clinical study of its wholly-owned lead product candidate, SLN124, for the treatment of 'iron-loading' anemias, thalassemia and myelodysplastic syndrome (MDS).

Read more
28 Apr 2021 19:20

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

Read more
28 Apr 2021 13:33

Silence Therapeutics gets $2m milestone payment from Mallinckrodt

(Sharecast News) - Silence Therapeutics has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt for complement-mediated diseases, it announced on Wednesday, triggering a further $2m payment.

Read more
19 Apr 2021 14:58

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

Read more
30 Mar 2021 20:33

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

Read more
23 Mar 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.